The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
@article{Ly2012TheIB,
title={The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007},
author={Kathleen N. Ly and Jian Xing and R. Monina Klevens and Ruth B. Jiles and John W. Ward and Scott Holmberg},
journal={Annals of Internal Medicine},
year={2012},
volume={156},
pages={271 - 278}
}BACKGROUND
The increasing health burden and mortality from hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States are underappreciated.
OBJECTIVE
To examine mortality from HBV; HCV; and, for comparison, HIV.
DESIGN
Analysis of U.S. multiple-cause mortality data from 1999 to 2007 from the National Center for Health Statistics.
SETTING
All U.S. states and the District of Columbia.
PARTICIPANTS
Approximately 22 million decedents.
MEASUREMENTS
Age-adjusted mortality…
Topics from this paper
711 Citations
Causes of death and characteristics of decedents with viral hepatitis, United States, 2010.
- MedicineClinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 2014
Demographic characteristics and the most frequent causes of death among decedents with a viral hepatitis-related death suggest and support the need for prevention, early identification, and treatment of HBV and HCV.
Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
- Medicine, BiologyWorld journal of gastroenterology
- 2017
Mortality rates associated with HCV infection increased exponentially with age in both genders, with a male to female ratio close to unity among the elderly; a further peak was observed in the 50-54 year age group especially among male subjects.
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
- MedicineGastroenterology
- 2018
The decrease in HCV-related mortality coincided with the introduction of direct-acting antiviral therapies, whereas mortality from ALD and nonalcoholic fatty liver disease increased during the same period.
Deaths among people with hepatitis C in New York City, 2000-2011.
- MedicineClinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 2014
HCV-infected adults were at increased risk of dying and of dying prematurely, particularly from conditions associated with HCV, such as HIV/AIDS or drug use, and the short interval between HCV report and death suggests a need for earlier testing and improved treatment.
The impact of chronic hepatitis C virus infection on mortality.
- Medicine, BiologyThe Journal of infectious diseases
- 2012
The mortality rates of subjects who were only HCV antibody positive were similar to the rates of those without markers of HCV, and the effect of chronic HCV infection on overall and specific causes of mortality was examined.
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010.
- Medicine, BiologyJournal of hepatology
- 2015
Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
- MedicineAnnals of Internal Medicine
- 2014
The estimated prevalence of chronic HCV infection in the United States has decreased and risk factors for infection are essentially unchanged from previous periods and were reported by only about one half of infected persons.
Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010
- MedicineBMC Infectious Diseases
- 2018
HCV infection disparities by sex are mostly consistent across the country, however, race differences in HCV infection differ by state and tailored prevention and treatment efforts specific to the local HCV epidemic are needed to reduce race disparities.
References
SHOWING 1-10 OF 63 REFERENCES
Changing trends in hepatitis C–related mortality in the United States, 1995‐2004
- MedicineHepatology
- 2008
Overall, hepatitis C mortality has increased substantially since 1995 and, despite small declines in recent years, rates have continued to increase among persons aged 55‐64 years.
Estimating future hepatitis C morbidity, mortality, and costs in the United States.
- MedicineAmerican journal of public health
- 2000
The results confirm prior Centers for Disease Control and Prevention projections and suggest that HCV may lead to a substantial health and economic burden over the next 10 to 20 years.
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
- MedicineAnnals of Internal Medicine
- 2006
To determine the characteristics of HCV-infected persons in the general United States population today and to monitor trends in prevalence, data on HCV infection from the most recent NHANES was analyzed.
All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.
- MedicineClinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 2011
Chronic HCV all-cause mortality is more than twice that of HCV-negative individuals, which suggests that those with chronic HCV infection are at a higher risk of death even after accounting for liver-related morbidity and should be closely monitored.
The prevalence of hepatitis B virus infection in the United States in the era of vaccination.
- MedicineThe Journal of infectious diseases
- 2010
HBV prevalence decreased among US children, which reflected the impact of global and domestic vaccination, but it changed little among adults, and approximately 730,000 US residents are chronically infected.
Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999.
- Medicine
- 2002
Advances in antiretroviral therapy probably caused deaths due to HIV infection to decrease after 1995, and the proportions of deaths with HIV that were caused by other conditions increased.
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.
- MedicineDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- 2011
Is chronic hepatitis B being undertreated in the United States?
- MedicineJournal of viral hepatitis
- 2011
Summary. Chronic infection with the hepatitis B virus (HBV) is a major risk factor for development of end‐stage liver disease, including cirrhosis, liver failure and primary liver cancer. There are…
Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study
- MedicineJournal of acquired immune deficiency syndromes
- 2006
Although overall death rates remained low through 2004, the proportion of deaths attributable to non- AIDS diseases increased and prominently included hepatic, cardiovascular, and pulmonary diseases, as well as non-AIDS malignancies.
Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C.
- Medicine
- 2010
Lack of awareness about the prevalence of chronic viral hepatitis in the United States and about the proper methods and target populations for screening and medical management of chronic hepatitis B and hepatitis C probably contributes to continuing transmission.